Table 1 Patient demographics and clinical characteristics
Nos. | Sex | Age | Eye | BCDVA (LogMAR) | Systemic disease | Eye disorder/previous ocular surgery | NK stage (Mackie) |
|---|---|---|---|---|---|---|---|
1 | M | 60 | OS | 0.9 | DM2, rheumatoid arthritis | Severe bacterial keratitis followed by PK in 2016, repeated AMTs | 2 |
2 | F | 79 | OS | 0.5 | SLE | PK for KC in 1976 | 2 |
3 | M | 88 | OS | 0.6 | – | Recurrent HSV keratitis | 3 |
4 | F | 61 | OS | 0.8 | GVHD | Ocular GVHD, pseudomonas keratitis in 2017, PK, RGTA and AMT for PED in 2017 | 3 |
5 | M | 61 | OS | 0.4 | – | Ocular trauma and PK in 1999, trabeculectomy in 2004 | 2 |
6 | F | 50 | OD | 0.9 | – | Eyelash ablation for trichiasis in 1982, exposure keratopathy surgically corrected in 2002, PK in 2015, AMT in 2016 | 2 |
7 | F | 64 | OD | 0.8 | – | PK in 1988 for KC, exposure keratopathy surgically corrected in 2016 | 3 |
8 | M | 65 | OS | 0.9 | – | Alkali burn in 2017 | 3 |
9 | F | 42 | OD | 0.6 | – | Recurrent HSV keratitis | 2 |
10 | F | 75 | OD | 0.8 | – | PK in 1991 for KC, repeated PK in 2004, lagophthalmos and exposure keratopathy surgically corrected in 2015 | 3 |
11 | M | 84 | OS | 0.4 | Prostatic hyperplasia, DM2, hyperlipemia | PK in 2018 for total corneal leucoma after Corynebacterium and Staphylococcal keratitis | 2 |
12 | M | 59 | OS | 0.5 | – | Retinal surgery for RD with 360° endolaser retinopexy in 2018 | 2 |
13 | F | 88 | OS | 0.4 | DM2, hypertension, hyperlipemia | Acoustic nerve surgery with trigeminal damage in 2010 | 2 |
14 | M | 62 | OD | 0.7 | Hypertension | Alkali burn in 2015 | 2 |
15 | F | 55 | OD | 0.4 | – | Retinal surgery for RD with 360° endolaser retinopexy in 2017 | 2 |
16 | F | 77 | OD | 0.5 | – | Two PK performed elsewhere, PK for corneal leukoma and edema in 2018, glaucoma treated with topical therapy | 2 |
17 | F | 39 | OS | 0.6 | DM2 | Retinal surgery with PRP in 2018 | 2 |
18 | F | 88 | OS | 0.6 | – | DSAEK in 2016 for Fuchs keratopathy, recurrent HZV keratitis | 2 |